Chronic obstructive pulmonary disease (COPD) is a group of long-term lung conditions — mainly emphysema and chronic bronchitis — that narrow the airways and make breathing progressively harder over time (MedlinePlus). Existing lung damage can't be reversed and there is no cure, but treatment can ease symptoms, slow the decline, and reduce flare-ups. Both the NHS and MedlinePlus are unambiguous about the single most important step: if you smoke, stopping is "the most important thing you can do" and "the most important step you can take to treat COPD" — it does more than any medicine to keep COPD from getting worse, and no inhaler substitutes for it. The mainstay of drug treatment is inhalers, which deliver medicine straight to the lungs: short-acting "reliever" inhalers (such as albuterol/salbutamol and ipratropium) ease sudden breathlessness and last about 4–6 hours, while long-acting bronchodilators (LABA and LAMA types) are taken on a regular schedule to keep the airways open for 12 hours or more, and inhaled steroids are added — usually inside a combination inhaler — for people who have frequent flare-ups (NHS, NHLBI). All of these are prescription-only, and the choice of drug, the inhaler device, and how medicines are combined are set by a clinician and matched to how severe the disease is. Beyond inhalers, pulmonary rehabilitation, flu and pneumococcal vaccination, and — for advanced disease with low blood-oxygen levels — home oxygen therapy are important parts of care (NHLBI, MedlinePlus). There is no over-the-counter medicine that treats COPD itself, so self-care centers on quitting smoking, staying active, and using prescribed inhalers correctly.
For options we rate, we show our independent FDA recall-safety rating(0–100) — a signal GoodRx and Drugs.com don’t provide. Higher is safer.
A doctor may prescribe these — not for self-treatment.
albuterol (salbutamol) Ventolin HFA, ProAir HFA Short-acting beta-2 agonist (SABA) — reliever inhaler | A quick-acting inhaler that relaxes the muscles around the airways to open them up, easing sudden breathlessness or wheeze usually within minutes; the effect lasts about 4–6 hours (NHLBI). Often called a rescue or reliever inhaler and used as needed rather than on a fixed schedule. A clinician decides whether it is used on its own or alongside long-acting maintenance inhalers. |
ipratropium Atrovent HFA; with albuterol as Combivent Respimat Short-acting antimuscarinic (SAMA) — reliever inhaler | Another type of short-acting reliever that opens the airways by blocking the nerve signals that tighten them (NHS). It may be prescribed on its own or combined with albuterol in a single reliever inhaler. Like other relievers, it is meant to ease symptoms as they occur rather than serve as the long-term controller. |
salmeterol, formoterol Serevent (salmeterol) Long-acting beta-2 agonist (LABA) — maintenance inhaler | A long-acting bronchodilator taken on a regular schedule to keep the airways open through the day; its effect lasts about 12 hours or more (NHLBI). Used for ongoing (maintenance) treatment of moderate-to-severe COPD, frequently as part of a combination inhaler. The specific drug and dose are set by a clinician. |
tiotropium, umeclidinium Spiriva (tiotropium), Incruse Ellipta (umeclidinium) Long-acting antimuscarinic (LAMA) — maintenance inhaler |
COPD medicines are prescribed as a stepwise plan tailored by a clinician, not chosen off a shelf — the NHS stresses that both the medicine and your inhaler technique are set and reviewed by a health professional, because a poorly used inhaler doesn't deliver the drug. For most people the foundation of regular treatment is one or two long-acting bronchodilators (a LABA, a LAMA, or both together), with a short-acting reliever kept on hand for sudden symptoms (NHLBI). An inhaled steroid is generally added — inside a combination inhaler — for people who keep having flare-ups; clinicians increasingly use a blood test (eosinophil count) to judge who is likely to benefit, since inhaled steroids also carry a higher pneumonia risk in COPD. Treatment is stepped up by combining medicines (dual, then "triple" inhalers) as symptoms or exacerbations continue, and oral roflumilast or, less commonly, theophylline may be added for severe disease. Flare-ups themselves are usually treated with short courses of steroid tablets and, when a chest infection is present, antibiotics — these are rescue treatments, not everyday ones. A clinician also weighs other conditions (heart disease, glaucoma, prostate or bladder problems), decides when home oxygen is needed based on blood-oxygen testing, and will usually recommend pulmonary rehabilitation plus yearly flu and pneumococcal vaccination (NHLBI, MedlinePlus). The consistent thread is that every one of these is a medical decision — the reader's role is to stop smoking, use what's prescribed correctly, keep up rehab and vaccines, and report changes, rather than to start, stop, or switch a drug alone.
See a doctor if you have a persistent cough, ongoing breathlessness, wheezing, or repeated chest infections — especially if you are over 35 and smoke or used to — because COPD is often diagnosed late, and earlier treatment together with stopping smoking slows the damage (NHS). If you already have COPD, contact your clinician promptly for signs of a flare-up (exacerbation): breathlessness that is worse than usual, more coughing, or a change in the color, thickness, or amount of your phlegm, which may need a rescue course of steroid tablets or antibiotics. Get emergency help — call 911 — for severe or sudden breathlessness that leaves you unable to speak in full sentences, chest pain, blue or grey lips or fingertips, a very fast heartbeat, or new confusion or drowsiness, as these can signal dangerously low oxygen or a serious flare that needs hospital care. Living with a long-term lung condition can also weigh on mood: tell your care team if you feel persistently low or anxious, because support is available, and if you ever have thoughts of harming yourself, call or text the 988 Suicide & Crisis Lifeline in the US (call or text 988) for immediate, free, confidential help.
General reference, not medical advice, and not a substitute for your doctor or pharmacist. The right choice depends on your symptoms, health conditions, age, and other medicines — always read each label and confirm before taking anything.
| A once- or twice-daily maintenance inhaler that keeps the airways relaxed by blocking airway-tightening signals for around 12–24 hours. Long-acting antimuscarinics and long-acting beta-2 agonists are the backbone of regular COPD treatment and are often used together (NHS, NHLBI). A clinician selects the drug and the inhaler device. |
fluticasone, budesonide in combination inhalers such as Advair, Symbicort Inhaled corticosteroid (ICS) — anti-inflammatory, usually within a combination inhaler | A steroid inhaler that reduces inflammation in the airways. In COPD it is normally prescribed as part of a combination inhaler (with one or two long-acting bronchodilators) rather than on its own, and is generally added for people who have frequent flare-ups (NHS). Because inhaled steroids can raise the risk of pneumonia in COPD, a clinician weighs the benefit case by case. |
combination inhalers Anoro Ellipta, Symbicort, Trelegy Ellipta Dual (LABA+LAMA) or triple (ICS+LABA+LAMA) maintenance inhalers | Single inhalers that combine two or three of the maintenance medicines above — a LABA plus a LAMA, an inhaled steroid plus a LABA, or all three ("triple therapy"). They are the usual way long-acting treatment is stepped up as COPD becomes more symptomatic or flare-ups continue. Which combination, if any, is a clinician's decision based on severity and flare-up history — not something to assemble yourself. |
Daliresp PDE4 inhibitor — oral anti-inflammatory tablet Our rating 60/100 | A daily tablet, not an inhaler, that reduces airway inflammation. The NHS notes it is used for severe COPD to help prevent flare-ups, generally added on top of inhalers for people with severe disease and chronic-bronchitis symptoms who keep having exacerbations. Nausea, diarrhea, and weight loss are common, so it is prescribed selectively and monitored. |
Theo-24, Elixophyllin Oral bronchodilator (methylxanthine) Our rating 72/100 | An older bronchodilator tablet used less often today, usually only when inhalers alone aren't enough (NHS). It needs blood-level monitoring because the helpful dose is close to the level that causes side effects, and it interacts with several other medicines — so it is managed carefully by a clinician. |
supplemental oxygen Long-term / ambulatory oxygen therapy | Not a medicine but extra oxygen delivered through nasal tubes or a mask, prescribed when COPD has lowered the oxygen level in the blood (NHS, MedlinePlus). It is used in advanced disease to protect the heart and other organs; the need for it and the flow rate are determined by a clinician using blood-oxygen testing. It is prescription-only and is not a treatment for breathlessness on its own. |